Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00272636 · ClinicalTrials.gov registry record · NA
Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT00272636 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 140 participants.
The verdict
NCT00272636, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the long-term efficacy of radiofrequency catheter ablation in patients with chronic atrial fibrillation.
Interventions
- PROCEDURE Radiofrequency catheter ablation
- DRUG Amiodarone and cardioversion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00272636
The ClinicalTrials.gov registry entry for NCT00272636 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Radiofrequency catheter ablation is the first listed.
NCT00272636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00272636 about?
NCT00272636 is a clinical study titled "Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation". The purpose of this study is to determine the long-term efficacy of radiofrequency catheter ablation in patients with chronic atrial fibrillation.
What is the current status of trial NCT00272636?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2002-11. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00272636?
The interventions under investigation include: Radiofrequency catheter ablation (PROCEDURE), Amiodarone and cardioversion (DRUG).
Who is sponsoring clinical trial NCT00272636?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.